The afferent system and its role in lower urinary tract dysfunction

Current Opinion in Urology

Volumn 21, Issue 4, 2011, Pages 268-274

  Daly, Donna M ^a   Collins, Valerie M ^b   Chapple, Christopher R ^c   Grundy, David ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

afferent; interstitial cystitis; mechanotransduction; overactive bladder syndrome; sensory; urothelium

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CHOLINERGIC RECEPTOR; MUSCARINIC RECEPTOR; NITRIC OXIDE; PURINERGIC P2X RECEPTOR; PURINERGIC P2X3 RECEPTOR; RAFABEGRON; SUBSTANCE P; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4;

BLADDER FUNCTION; BLADDER INNERVATION; BLADDER NECK STENOSIS; HUMAN; INTERSTITIAL CYSTITIS; LOWER URINARY TRACT SYMPTOM; LUMBOSACRAL PLEXUS; MECHANOTRANSDUCTION; MEDIATOR RELEASE; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; SPINAL GANGLION; UROTHELIUM;

AFFERENT PATHWAYS; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; ION CHANNELS; MECHANOTRANSDUCTION, CELLULAR; RECEPTORS, NEUROTRANSMITTER; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; UROTHELIUM;

EID: 79959207561     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283476ea2     Document Type: Review

References (57)

1. Rong W, Spyer KM, Burnstock G. Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol 2002; 541:591-600 (Pubitemid 35190224)
2. Sengupta JN, Gebhart GF. Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol 1994; 72:2420-2430 (Pubitemid 24362634)
3. Zagorodnyuk VP, Gibbins IL, Costa M, et al. Properties of the major classes of mechanoreceptors in the guinea pig bladder. J Physiol 2007; 585:147-163 (Pubitemid 350131109)
4. Page AJ, O?Donnell TA, Cooper NJ, et al. Nitric oxide as an endogenous peripheral modulator of visceral sensory neuronal function. J Neurosci 2009; 29:7246-7255
5. Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ. Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment. Eur Urol 2010; 59:264-271
6. Caremel R, Oger-Roussel S, Behr-Roussel D, et al. Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. Eur Urol 2010; 58:616-625.
7. Ozawa H, Chancellor MB, Jung SY, et al. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol 1999; 162:2211-2216
8. Behr-Roussel D, Oger S, Caisey S et al. Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats. Eur Urol 2010; 59:272-279
9. Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes: a possible sensory mechanism? J Physiol 1997; 505 (Pt 2):503-511 (Pubitemid 28043392)
10. Vlaskovska M, Kasakov L, Rong W, et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 2001; 21:5670-5677 (Pubitemid 32692165)
11. Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes: a possible sensory mechanism? J Physiol 1997; 505 (Pt 2):503-511 (Pubitemid 28043392)
12. Vlaskovska M, Kasakov L, Rong W, et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 2001; 21:5670-5677 (Pubitemid 32692165)
13. Sadananda P, Shang F, Liu L, et al. Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretch. British Journal of Pharmacology 2009; 158:1655-1662
14. Kumar V, Chapple CR, Surprenant AM, Chess-Williams R. Enhanced adenosine triphosphate release from the urothelium of patients with painful bladder syndrome: a possible pathophysiological explanation. J Urol 2007; 178:1533-1536 (Pubitemid 47368381)
15. Kumar V, Chapple CR, Rosario D, et al. In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic. Eur Urol 2010; 57:1087-1092
16. Munoz A, Gangitano D, Smith C et al. Removal of urothelium affects bladder contractility and release of ATP but not release of NO in rat urinary bladder. BMC Urol 2010; 10:10
17. Munoz A, Smith CP, Boone TB, Somogyi GT. Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release. Neurochem Int 2010; 58:295-300
18. Yoshida M, Inadome A, Maeda Y, et al. Nonneuronal cholinergic system in human bladder urothelium. Urology 2006; 67:425-430 (Pubitemid 43189886)
19. De Wachter S, Wyndaele JJ. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol 2003; 169:1892-1895 (Pubitemid 36443540)
20. Iijima K, De Wachter S, Wyndaele JJ. Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve. Eur Urol 2007; 52:842-847
21. Matsumoto Y, Miyazato M, Furuta A, et al. Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats. Urology 2010; 75:862-867
22. Masuda H, Ichiyanagi N, Yokoyama M, et al. Muscarinic receptor activation in the lumbosacral spinal cord ameliorates bladder irritation in rat cystitis models. BJU Int 2009; 104:1531-1537
23. Daly DM, Chess-Williams R, Chapple C, Grundy D. The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity. Eur Urol 2010; 58:22-32
24. Hanna-Mitchell AT, Beckel JM, Barbadora S, et al. Nonneuronal acetylcholine and urinary bladder urothelium. Life Sci 2007; 80:2298-2302 (Pubitemid 46818280)
25. Kullmann FA, Artim D, Beckel J, et al. Heterogeneity of muscarinic receptormediated Ca2? responses in cultured urothelial cells from rat. Am J Physiol Renal Physiol 2008; 294:F971-F981
26. Hawthorn MH, Chapple CR, Cock M, Chess-Williams R. Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 2000; 129:416-419 (Pubitemid 30083861)
27. Yu Y, de Groat WC. Effects of stimulation of muscarinic receptors on bladder afferent nerves in the in vitro bladder-pelvic afferent nerve preparation of the rat. Brain Res 2010; 1361:43-53
28. Nandigama R, Bonitz M, Papadakis T, et al. Muscarinic acetylcholine receptor subtypes expressed by mouse bladder afferent neurons. Neuroscience 2010; 168:842-850
29. Schurch B, Hauri D, Rodic B, et al. Botulinum-A Toxin as a Treatment of Detruosor-Sphincter Dyssynergia: a prospective study in 24 spinal cord injury patients. Journal of Urol 1996; 155:1023-1029 (Pubitemid 26052703)
30. Khan S, Kessler TM, Apostolidis A, et al. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection. J Urol 2009; 181:1773-1778
31. Lucioni A, Bales GT, Lotan TL, et al. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int 2008; 101:366-370
32. Khera M, Somogyi GT, Salas NA, et al. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology 2005; 66:208-212 (Pubitemid 41002229)
33. Collins VM, Chapple CR, McKay NG, et al. Botulinum toxin attenuates sensory afferent nerve firing in an ex vivo mouse bladder model. J Urol 2009; 181:82-83
34. Apostolidis A, Popat R, Yiangou Y, et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005; 174:977-983
35. Coelho A, Dinis P, Pinto R, et al. Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder. Eur Urol 2010; 57:884-890
36. Chuang Y-C, Tyagi P, Huang C-C, et al. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes. J Urol 2009; 182:786-792
37. Zagorodnyuk VP, Brookes SJ, Spencer NJ, Gregory S. Mechanotransduction and chemosensitivity of two major classes of bladder afferents with endings in the vicinity to the urothelium. J Physiol 2009; 587:3523-3538
38. Apostolidis A, Brady CM, Yiangou Y, et al. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology 2005; 65:400-405 (Pubitemid 40248050)
39. Birder LA, Nakamura Y, Kiss S, et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002; 5:856-860 (Pubitemid 34976650)
40. Everaerts W, Vriens J, Owsianik G, et al. Functional characterization of transient receptor potential channels in mouse urothelial cells. Am J Physiol Renal Physiol 2010; 298:F692-F701
41. Yu W, Hill WG, Apodaca G, Zeidel ML. Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium. Am J Physiol Renal Physiol 2010; 300:F49-F59
42. Hayashi T, Kondo T, Ishimatsu M, et al. Expression of the TRPM8-immunoreactivity in dorsal root ganglion neurons innervating the rat urinary bladder. Neurosci Res 2009; 65:245-251
43. Lashinger ES, Steiginga MS, Hieble JP, et al. AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome. Am J Physiol Renal Physiol 2008; 295:F803-F810
44. Gevaert T, Vriens J, Segal A, et al. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 2007; 117:3453-3462 (Pubitemid 350097001)
45. Mochizuki T, Sokabe T, Araki I, et al. The TRPV4 cation channel mediates stretch-evoked Ca2? influx and ATP release in primary urothelial cell cultures. J Biol Chem 2009; 284:21257-21264
46. Freeman R, Adekanmi O, Waterfield M, et al. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:636-641 (Pubitemid 44575283)
47. Hayn MH, Ballesteros I, de Miguel F, et al. Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Urology 2008; 72:1174-1178
48. Walczak JS, Price TJ, Cervero F. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience 2009; 159:1154-1163
49. Tyagi V, Philips BJ, Su R, et al. Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 2009; 181:1932-1938
50. Mukerji G, Yiangou Y, Agarwal SK, Anand P. Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms. Urology 2010; 75:1514e15-1514e20
51. Gratzke C, Streng T, Park A, et al. Distribution and Function of Cannabinoid Receptors 1 and 2 in the Rat, Monkey and Human Bladder. The Journal of Urology 2009; 181:1939-1948
52. Trevisani M, Campi B, Gatti R, et al. The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract. Eur Urol 2007; 52:901-908 (Pubitemid 47126136)
53. Yanase H, Wang X, Momota Y, et al. The involvement of urothelial alpha-1-A adrenergic receptor in controlling the micturition reflex. Biomed Res 2008; 29:239-244
54. Yoshizumi M, Matsumoto-Miyai K, Yonezawa A, Kawatani M. Role of supraspinal and spinal alpha1-adrenergic receptor subtypes in micturition reflex in conscious rats. Am J Physiol Renal Physiol 2010; 299:F785-F791
55. Yazaki J, Aikawa K, Shishido K, et al. Alpha-1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction. Neurourol Urodyn 2010; 30:461-467
56. Nagabukuro H, Degenhardt A, Villa KL, et al. Correlation between pharmacologically- induced changes in cystometric parameters and spinal c-Fos expression in rats. Auton Neurosci 2010; 156:19-26
57. Kullmann FA, Downs TR, Artim DE, et al. Urothelial beta-3 adrenergic receptors in the rat bladder. Neurourol Urodyn 2010; 30:144-150